» Articles » PMID: 28462854

Characterization of Carbapenemases, ESBLs, and Plasmid-mediated Quinolone Determinants in Carbapenem-insensitive Escherichia Coli and Klebsiella Pneumoniae in Riyadh Hospitals

Overview
Publisher Elsevier
Date 2017 May 3
PMID 28462854
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The main objective of this work was to characterize carbapenemases, extended-spectrum β-lactamases (ESBLs), and plasmid-mediated quinolone resistance (PMQR) among carbapenem-insensitive Klebsiella pneumoniae and Escherichia coli clinical isolates which were isolated from three hospitals in Riyadh. Thirty-one carbapenem-insensitive isolates (21 K. pneumoniae and 10 E. coli) were recovered from March 2014 to May 2014. Susceptibility testing and phenotypic detection tests were used to characterize the classes of β-lactamases. PCR assays were performed for the detection of the genes encoding ESBL (bla, blabla, and bla), carbapenemase (blablabla, bla, bla, and bla), and PMQR (qnrA, qnrB, qnrS, aac(6)-Ib-cr, qepA, oqxA, and oqxB) genes. All carbapenem-insensitive isolates were carbapenemase producers, with 41.9% and 58.1% being class B carbapenemases class D OXA-48, respectively. While the prevalence of ESBL producers was 80.6%. The following resistance genes were detected; OXA-48-like (58.1%), NDM-type (41.9%), CTX-M-1-like (77.4%), CTX-M-9-like (9.6%), TEM-1 (74.2%), OXA-1 (54.8%), SHV-1 (4.4%), qnrS (58.1%), qnrB (3.2%), and aac(6)-Ib-cr (51.6%). The predominant carbapenemases in the isolates that had carbapenem MIC≤4μg/ml and MIC≥12μg/ml were bla and bla respectively. CTX-M-1-like and qnrS were the dominant ESBL and PMQR genes, respectively. This is the first report in which qnrS was described in the isolates from Saudi Arabia.

Citing Articles

Systematic review of multidrug-resistant in the Arabian Peninsula: molecular epidemiology and resistance patterns.

Idrees E, Aldriwesh M, Alkhulaifi M, Alghoribi M Front Microbiol. 2025; 16:1489317.

PMID: 39927260 PMC: 11802542. DOI: 10.3389/fmicb.2025.1489317.


Prevalence and genetic characterization of clinically relevant extended-spectrum β-lactamase-producing in the Gulf Cooperation Council countries.

Hadi H, Al-Hail H, Aboidris L, Al-Orphaly M, Ahmed M, Samuel B Front Antibiot. 2025; 2():1177954.

PMID: 39816644 PMC: 11732020. DOI: 10.3389/frabi.2023.1177954.


Unveiling the potential of spirulina algal extract as promising antibacterial and antibiofilm agent against carbapenem-resistant Klebsiella pneumoniae: in vitro and in vivo study.

Selim M, El-Banna T, Sonbol F, Negm W, Elekhnawy E Microb Cell Fact. 2025; 24(1):7.

PMID: 39755644 PMC: 11700449. DOI: 10.1186/s12934-024-02619-3.


Surveillance of public health pathogens in Lagos wastewater canals: a cross-sectional study.

Chukwu E, Okwuraiwe A, Kunle-Ope C, Igbasi U, Onyejepu N, Osuolale K BMC Public Health. 2024; 24(1):3590.

PMID: 39725906 PMC: 11670414. DOI: 10.1186/s12889-024-21157-6.


The Challenge of Treating Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria: A Narrative Review.

Hidalgo-Tenorio C, Bou G, Oliver A, Rodriguez-Aguirregabiria M, Salavert M, Martinez-Martinez L Drugs. 2024; 84(12):1519-1539.

PMID: 39467989 PMC: 11652570. DOI: 10.1007/s40265-024-02102-8.